Adopting a strategy for universal screening with opt-out for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) for your female patients ages 15-24 can help:
|
Identify more at-risk patients |
|
Initiate timely treatment |
|
Decrease transmission |
|
Protect patient’s fertility |
Access resources to help you integrate universal screening with opt-out
Our practice support resources include:
- A 1-page overview on how to implement universal screening with opt-out into your practice
- An accompanying brochure that goes into detail on overcoming patient objections to universal screening and talking about test results
As part of mandatory reporting requirements to identify potential abuse, when testing minors under the age of consent, healthcare professionals may be required in certain jurisdictions to report positive results of sexually transmitted disease testing to authorities.
Image content features models and is intended for illustrative purposes only.